The Use of Survival Dose-Rate Dependencies as Theoretical Discrimination Criteria for In-Silico Dynamic...

Area of Science:

• Radiobiology
• Computational Biology
• Cancer Therapy Optimization

Background:

• Cell repair dynamics are critical for effective anti-cancer treatments, but interpreting experimental data like comet assays and γ-H2AX is complex.
• Model-based analysis is necessary for understanding repair kinetics, yet parameter calibration ambiguities persist.
• Existing methods struggle with the intricacies of post-radiation repair kinetics and dose-rate effects.

Purpose of the Study:

• To develop a robust methodology for analyzing cell repair kinetics by integrating survival dose-rate effects with computer simulations.
• To address and resolve ambiguities in parameter calibration for radiobiological models.
• To enhance the optimization of anti-cancer therapies through improved understanding of cellular repair.

Main Methods:

• A literature review identified theoretical discriminators based on fractionation/dose-rate effects to refine model dynamics.
• The Multi-Hit Repair (MHR) model was calibrated using canine osteosarcoma Abrams cell line data, particularly in low-survival data scenarios.
• Human SiHa cervical cancer cell line data were utilized to demonstrate MHR's capability in modeling survival behavior across various dose rates.

Main Results:

• The proposed discriminators effectively filtered 99% of parameter sets, significantly improving the calibration of the Abrams cell line data.
• SiHa cell line data validated the efficacy of the theoretical discriminators.
• Analysis of both cell lines suggests potential universal characteristics of cellular repair mechanisms.

Conclusions:

• Theoretical discrimination criteria based on dose-rate effects offer an effective strategy for understanding repair kinetics and refining radiobiological model calibration.
• This computational methodology can be applied to analyze diverse biological data using dynamic models *in-silico*.
• The findings contribute to advancing anti-cancer therapy optimization through enhanced modeling of cellular repair.